Marker Therapeutics's total assets for Q2 2025 were $14.77M, a decrease of -13.10% from the previous quarter. MRKR total liabilities were $4.28M for the fiscal quarter, a 71.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.